Skip to main content

Peer Review reports

From: The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma

Original Submission
26 Jan 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Apr 2023 Reviewed Reviewer Report
5 May 2023 Reviewed Reviewer Report
16 May 2023 Author responded Author comments - Panfeng Shang
Resubmission - Version 3
16 May 2023 Submitted Manuscript version 3
24 May 2023 Author responded Author comments - Panfeng Shang
Resubmission - Version 4
24 May 2023 Submitted Manuscript version 4
8 Jun 2023 Author responded Author comments - Panfeng Shang
Resubmission - Version 5
8 Jun 2023 Submitted Manuscript version 5
17 Jun 2023 Author responded Author comments - Panfeng Shang
Resubmission - Version 6
17 Jun 2023 Submitted Manuscript version 6
2 Jul 2023 Reviewed Reviewer Report
20 Jul 2023 Author responded Author comments - Panfeng Shang
Resubmission - Version 7
20 Jul 2023 Submitted Manuscript version 7
Publishing
19 Sep 2023 Editorially accepted
16 Oct 2023 Article published 10.1186/s12885-023-11419-8

You can find further information about peer review here.

Back to article page